Vladimir Putin Says Will Get Inoculated 'Russian-Made' COVID-19 Vaccine When Possible

Emmanuel Macron Tests Positive For COVID-19; French President to Self-Isolate Himself

PM Narendra Modi and Bangladesh PM Sheikh Hasina Jointly Inaugurate Chilahati-Haldibari Rail Link

Tokyo Hospitals on Red Alert After City Records Highest COVID-19 Cases on Thursday

China’s Spacecraft Chang’e-5 Successfully Touches Down on Earth With Moon Samples

Berlin Film Festival 2021 Might Go Virtual For the First Time Due to COVID-19 Scare

US COVID-19 Vaccination Programme: Health Worker Suffers Severe Allergic Reaction Minutes After Getting Pfizer-BioNTech's Vaccine Shot

Winter Storm Gail in Northeast US: Heavy Snow Storm Covers Parts of New York, Boston, Philadelphia in Thick Blanket of Snow (See Photos and Videos)

COVID-19 Vaccine Update: Here's Why the European Union is Taking So Long to Approve Coronavirus Vaccine

Senate Hearing Elevates Donald Trump’s Baseless Claims of Election Fraud, Two Days After Joe Biden’s Victory Sealed by Electoral College

Nigerian President Muhammadu Buhari Orders Immediate Reopening of Land Borders Shut In a Bid to Curb Smuggling

Cyberattack on US Govt Agencies Still Underway: FBI, Intelligence Agencies

US Angling to Secure More of Pfizer's Coronavirus Vaccine After Country Sets a 24-Hour Record With 2.5 Lakh New COVID-19 Cases

Donald Trump Administration Cuts $200 Million From California's Healthcare Funding Over Abortions

Year Ender 2020: The Year of COVID-19, Lockdowns, Crippled Economies & Now Hope as We Ring in 2021

US Sets a 24-Hour Record With 3,700 COVID-19 Deaths & 250,000 New Cases

New Zealand Recovers Sharply From COVID-19 Induced Recession With Record Growth of 14% in July-September Quarter

Assam Reports 97 New COVID-19 Cases on Wednesday: Live Breaking News Headlines & Coronavirus Updates, December 16, 2020

Kenyan Man Cholo Abdi Abdullah Charged With Plotting 9/11-Style Terror Attack on US on Behalf of Al-Shabab

COVID-19 Vaccine: China Secures Deal for 100 Million Pfizer-BioNTech Doses as Domestic Drugmakers Yet to Attain Approval

Categories